Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microneedling With i-PRF vs HA for Papilla Reconstruction
NCT07280507Phase 1Active, not recruiting
- Sponsor
- King Abdulaziz University
- Start
- Nov 2025
- Primary completion
- Mar 2026
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, randomised trial of injectable platelet-rich fibrin (2 arms), sponsored by King Abdulaziz University. Primary endpoints: Papillary height at 12 weeks and Papillary width at 12 weeks. Started Nov 2025; status: active, not recruiting.
02
Drugs
injectable platelet-rich fibrin
Beyond the preview
Go deeper on NCT07280507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07280507.